BORNEM PHARMA
Board
1 director, last change in 2019Director (not named in the articles), permanent representative
since 01-09-2019
term without a fixed end
listed in the 2025 annual accounts, filed on 06-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 05-09-2019
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Manager
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Director (not named in the articles), from 01-09-2019 to date
-
- Manager, until 31-08-2019
Control
Parent
Equity €1.1m
Profit €214,039 in 2025 (profit €182,869 in 2024)
Checked score
Source: accounts 2025
100%
This company
BORNEM PHARMA
Equity €303,310
Profit €247,989 in 2025
Capital
- Contribution
- €18,600
- Source
- deed of 05-09-2019
Owners through the years
as the annual accounts name themOwners as a list
-
- 2019 to 2025: 100%
Source: lists of holdings in the owners' accounts
Articles of association
deed of 05-09-2019 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Thursday of June at 20:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Om welke reden en op welk ogenblik ook, één of meerdere vereffenaars aanduiden,bevoegdheden omlijnen,vergoeding bepalen”